1. General Information About Gestational Trophoblastic Disease

2. Commonly used synonyms Gestational trophoblastic disease (GTD) may also be called gestational trophoblastic tumour (GTT). Hydatidiform mole (one type of GTD) may also be called molar pregnancy. Persistent disease; persistent GTD: If there is any evidence of persistence of GTD, usually defined as persistent elevation of beta hCG (see «Diagnosis» below), the condition may also be referred to as gestational trophoblastic neoplasia (GTN).

3. Types GTD is the common name for five closely related tumours (one benign tumour, and four malignant tumours):benign tumourmalignant tumours The benign tumour  Hydatidiform mole Hydatidiform mole Here, first a fertilised egg implants into the uterus, but some cells around the fetus (the chorionic villi) do not develop properly. The pregnancy is not viable, and the normal pregnancy process turns into a benign tumour. There are two subtypes of hydatidiform mole: complete hydatidiform mole, and partial hydatidiform mole. The four malignant tumours  Invasive mole Invasive mole  Choriocarcinoma Choriocarcinoma  Placental site trophoblastic tumour Placental site trophoblastic tumour  Epithelioid trophoblastic tumour All five closely related tumours develop in the placenta. All five tumours arise from trophoblastic cells. The trophoblast is the membrane that forms the wall of the blastocyst in the early development of the fetus. In a normal pregnancy, trophoblastic cells aid the implantation of the fertilised egg into the uterine wall. But in GTD, they develop into tumour cells.trophoblastblastocyst

4. Incidence Overall, GTD is a rare disease. Nevertheless, the incidence of GTD varies greatly between different parts of the world. The reported incidence of hydatidiform mole ranges from 23 to 1299 cases per 100,000 pregnancies. The incidence of the malignant forms of GTD is much lower, only about 10% of the incidence of hydatidiform mole. The reported incidence of GTD from Europe and North America is significantly lower than the reported incidence of GTD from Asia and South America. One proposed reason for this great geographical variation is differences in healthy diet in the different parts of the world (e.g., carotene deficiency). However, the incidence of rare diseases (such as GTD) is difficult to measure, because epidemiologic data on rare diseases is limited. Not all cases will be reported, and some cases will not be recognised. In addition, in GTD, this is especially difficult, because one would need to know all gestational events in the total population. Yet, it seems very likely that the estimated number of births that occur at home or outside of a hospital has been inflated in some reports.

5. Risk Factors Two main risk factors increase the likelihood for the development of GTD: 1) The woman being under 20 years of age, or over 35 years of age, and 2) previous Although molar pregnancies affect women of all ages, women under 16 years of age have a six times higher risk of developing a molar pregnancy than those aged 16–40 years, and women 50 years of age or older have a one in three chance of having a molar pregnancy Being from Asia/of Asian ethnicity is an important risk factor. The ABO blood groups of the parents appear to be a factor in choriocarcinoma development, i.e. women with blood group A have been shown to have a greater risk than blood group O women.

7. Classification and external resources MicrographMicrograph of intermediate trophoblast, deciduaand a hydatidiform mole (bottom of image)intermediate trophoblastdecidua

8. Diagnosis Cases of GTD can be diagnosed through routine tests given during pregnancy, such as blood tests and ultrasound, or through tests done after miscarriage or abortion.Vaginal bleeding, enlarged uterus, pelvic pain or discomfort, and vomiting too much (hyperemesis) are the most common symptoms of GTD. But GTD also leads to elevated serum hCG (human chorionic gonadotropinhormone). Since pregnancy is by far the most common cause of elevated serum hCG, clinicians generally first suspect a pregnancy with a complication. However, in GTD, the beta subunit of hCG (beta hCG) is also always elevated. Therefore, if GTD is clinically suspected, serum beta hCG is also measured.hyperemesishuman chorionic gonadotropin The initial clinical diagnosis of GTD should be confirmed histologically, which can be done after the evacuation of pregnancy (see «Treatment» below) in women with hydatidiform mole.However, malignant GTD is highly vascular. If malignant GTD is suspected clinically, biopsy is contraindicated, because biopsy may cause life threatening haemorrhage.

10. Treatment Treatment is always necessary. The treatment for hydatidiform mole consists of the evacuation of pregnancy. Evacuation will lead to the relief of symptoms, and also prevent later complications. Suction curettage is the preferred method of evacuation. Hysterectomy is an alternative if no further pregnancies are wished for by the female patient. Hydatidiform mole also has successfully been treated with systemic (intravenous) methotrexate.Suction curettageHysterectomy The treatment for invasive mole or choriocarcinoma generally is the same. Both are usually treated with chemotherapy. Methotrexateand dactinomycin are among the chemotherapy drugs used in GTD. Only a few women with GTD suffer from poor prognosis metastatic gestational trophoblastic disease. Their treatment usually includes chemotherapy. Radiotherapy can also be given to places where the cancer has spread, e.g. the brain.MethotrexatedactinomycinchemotherapyRadiotherapy Women who undergo chemotherapy are advised not to conceive for one year after completion of treatment. These women also are likely to have an earlier menopause. It has been estimated by the Royal College of Obstetricians and Gynaecologists that the age at menopause for women who receive single agent chemotherapy is advanced by 1 year, and by 3 years for women who receive multi agent chemotherapy.

11. Ectopic pregnancy

12. An ectopic pregnancy, or eccysis, is a complication of pregnancy in which the embryo implants outside the uterine cavity.[1] With rare exceptions, ectopic pregnancies are not viable. Furthermore, they are dangerous for the mother, since internal haemorrhage is a life threatening complication. Most ectopic pregnancies occur in the Fallopian tube (so-called tubal pregnancies), but implantation can also occur in the cervix, ovaries, and abdomen. An ectopic pregnancy is a potential medical emergency, and, if not treated properly, can lead to death.

13. Classification Tubal pregnancy Nontubal ectopic pregnancy Heterotopic pregnancy Persistent ectopic pregnancy

14. Signs and symptoms Early symptoms are either absent or subtle. Clinical presentation of ectopic pregnancy occurs at a mean of 7.2 weeks after the last normal menstrual period, with a range of 5 to 8 weeks. Later presentations are more common in communities deprived of modern diagnostic ability.

15. Early signs include: Pain in the lower abdomen, and inflammation (pain may be confused with a strong stomach pain, it may also feel like a strong cramp). Pain while urinating. Pain and discomfort, usually mild. A corpus luteum on the ovary in a normal pregnancy may give very similar symptoms. Vaginal bleeding, usually mild. An ectopic pregnancy is usually a failing pregnancy and falling levels of progesterone from the corpus luteum on the ovary cause withdrawal bleeding. This can be indistinguishable from an early miscarriage or the 'implantation bleed' of a normal early pregnancy. Pain while having a bowel movement.

16. Patients with a late ectopic pregnancy typically experience pain and bleeding. This bleeding will be both vaginal and internal and has two discrete pathophysiologic mechanisms: External bleeding is due to the falling progesterone levels. Internal bleeding (hematoperitoneum) is due to hemorrhage from the affected tube.

17. Causes There are a number of risk factors for ectopic pregnancies. However, in as many as one third to one half of ectopic pregnancies, no risk factors can be identified. Risk factors include: pelvic inflammatory disease, infertility, use of an intrauterine device (IUD), previous exposure to DES, tubal surgery, intrauterine surgery (e.g. D&C), smoking, previous ectopic pregnancy, and tubal ligation.pelvic inflammatory diseaseinfertilityintrauterine deviceDESD&Csmokingtubal ligation Although older texts suggest an association between endometriosis and ectopic pregnancy this is not evidence based and current research suggests no association between endometriosis and ectopic pregnancy.

18. Genikological examination Dark, containing some blood separations Neck wombs cianotic. A bimanualy study: The womb soft, more rates can be a painful Apurtenance are increased only on the one hand, is defined thick formation. Codes can be thicking

19. DIAGNOSIS EXTRA UTERINE PREGNANSY DIFENETION HG USD the organs small pelvis Kuldocentez Gistological study endometry Laparoskopy

20. DIFFERENSIAL DIAGNOSIS Uterin spontaneous abort Аpoplex in ovarii Acute appendicites The inflamittion tuba ovarii

21. ECTOPIC PREGNANCY Meeting 1 -6% accidentally ginecological patient In flow differenc progressy pregnancy and interrupt In types -tubaovarial abortion or tuboovarial rupture.

22. Extra uterine pregnancy

23. AT BREAKUP OF THE UTERINE tube suddenly appear sharp pains in bottom of the belly with irradiation on rectum, blade with loss of the consciousness

24. On type of the tubaovarial abortion Appear attack form to pains in bottom of the abdomen Appear bleeding separations.

25. CLINICAL PICTURE Delay to menstruations, simptomy pregnancy, positive HGG vaginal bleeding to spastic pain adown belly and in loin

26. CLINICAL Pains in right or left of the area with irradation in rectum or on internal surface the right clavical area or suprakindney area Signs to anemias or bleedings: dizziness, weakness, Pale of the skin

27. THANK YOU FOR ATTENTION !!!